Temozolomide News and Research

RSS
Mouse model tightly matches pediatric tumor syndrome, will speed drug hunt

Mouse model tightly matches pediatric tumor syndrome, will speed drug hunt

Investigational treatment for advanced melanoma to be studied

Investigational treatment for advanced melanoma to be studied

Advanced melanoma - new treatment

Advanced melanoma - new treatment

Radiation plus chemo quadruples survival time for fatal brain cancer

Radiation plus chemo quadruples survival time for fatal brain cancer

New anti-cancer drug made from corn lillies kills brain tumor stem cells

New anti-cancer drug made from corn lillies kills brain tumor stem cells

Barr confirms patent challenge of TEMODAR

Barr confirms patent challenge of TEMODAR

Chemotherapy may enhance the effectiveness of the vaccines

Chemotherapy may enhance the effectiveness of the vaccines

Chemotherapy drug temozolomide shrinks brain tumors

Chemotherapy drug temozolomide shrinks brain tumors

Promising chemo, therapeutic viruses, cutting-edge surgery debut at M. D. Anderson Cancer Center

Promising chemo, therapeutic viruses, cutting-edge surgery debut at M. D. Anderson Cancer Center

New hope for patients with metastatic melanoma

New hope for patients with metastatic melanoma

Study examines biomarkers for response to erlotinib in glioma

Study examines biomarkers for response to erlotinib in glioma

European approval of Temodal (temozolomide) capsules for treatment of glioblastoma multiforme

European approval of Temodal (temozolomide) capsules for treatment of glioblastoma multiforme

Approval for Temodar (temozolomide) capsules for newly diagnosed glioblastoma multiforme

Approval for Temodar (temozolomide) capsules for newly diagnosed glioblastoma multiforme

New chemotherapy gives hope to brain tumour patients

New chemotherapy gives hope to brain tumour patients

Trial shows which brain cancer patients benefit from temozolomide

Trial shows which brain cancer patients benefit from temozolomide

50,000 people in the U.S. with cancer, multiple sclerosis, rheumatoid arthritis or hepatitis C will be eligible for a Medicare drug lottery

50,000 people in the U.S. with cancer, multiple sclerosis, rheumatoid arthritis or hepatitis C will be eligible for a Medicare drug lottery